Systemic Biochemical Signature and Functional Quality Index of Calcaneal Bone Marrow Aspirate in Adults Undergoing Foot or Ankle Surgery
This observational study is investigating how routine blood test results relate to the healing quality of stem cells taken from the heel bone (calcaneus) in adults undergoing foot or ankle surgery. Researchers will collect bone marrow from the surgical site and study the mesenchymal stem cells in the laboratory, examining their ability to grow, form bone, and control inflammation. The study aims to build a composite 'Functional Quality Index' from ordinary blood tests and determine whether it predicts how well these stem cells function. It is currently recruiting participants aged 40 to 80, with or without type 2 diabetes and diabetic foot ulcers, at a university hospital in Bragança Paulista, Brazil. Recruitment is expected to begin in October 2026. For DFU patients, this matters because stem cell therapies are a promising but still experimental option for hard-to-heal wounds, and better ways to predict who will benefit could make future treatments safer and more targeted. China's specialist DFU centres are actively exploring cell-based and regenerative approaches, so findings from this kind of biomarker research could eventually inform how such therapies are selected and monitored there.
Key takeaways
- This is an observational study, not a trial of a new drug or device: no experimental treatment is being given, and bone marrow is collected only during surgery that is already clinically needed.
- It focuses on building a blood-test-based index that may predict stem cell quality, which could one day help doctors choose the right patients for cell therapy.
- The study is only available in Bragança Paulista, Brazil, so international patients cannot enroll unless they travel there.
- Patients with diabetic foot ulcers are explicitly included, but participation requires a clinically indicated foot or ankle operation.
- Ask your doctor whether stem cell or bone marrow treatments are appropriate for your wound, and whether blood markers such as inflammation or glucose control could affect healing.
Read the full paper / source →
This content summarizes published medical research for educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making treatment decisions.
Free consultation
Could this treatment help you?
Our DFU specialists review every inquiry personally. Tell us about your situation — response within 48 hours, no commitment required.
This website provides medical-information science popularization only. It does NOT provide online diagnosis, prescriptions, or medical advice. Consult a licensed physician for any medical decision.
Editor's note
This research is trying to understand what makes a person's own bone marrow stem cells good at repairing tissue, so that future cell treatments can be matched to the patients most likely to benefit. If your wound has not healed with standard care or you have been told amputation may be needed, cell-based approaches are one of several emerging options, but they remain experimental and are not a guaranteed alternative to surgery. In China, specialist DFU centres already offer various regenerative and cell-based treatments in certain settings, but availability, regulation, and evidence vary. If you are considering care overseas, ask for clear evidence about the specific cell product, how it is prepared, and what outcomes have been documented, and discuss all options with your treating team before making decisions.